Subtype
Early Stage Breast Carcinoma
CI-CAN-00002563Explore in graph →
57 active trials2 approved drugs
- NCIt
- C94774
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002563Explore in graph →
Clinical trials
145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (13)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05377684 | Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment(ROSE) | completed | — | 450 | IpsenINDUSTRY | 1 | Jul 10, 2026 | clinicaltrials |
| NCT03664687 | Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)(REaCT-ZOL) | completed | Phase 4 | 211 | Ottawa Hospital Research InstituteOTHER |
| 1 |
| Jul 7, 2026 |
| clinicaltrials |
| NCT07521397 | Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study.(ΗE_10R/22) | completed | — | 5,358 | Hellenic Cooperative Oncology GroupOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT02129686 | A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients | completed | N/A | 57 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT05528263 | Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)(PACT) | completed | N/A | 89 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT02212860 | Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy(SIGNAL 2) | completed | N/A | 139 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT05945290 | Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer | completed | — | 114 | Mayo ClinicOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04290897 | Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors | completed | Phase 2 | 18 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT04829643 | Axillary Staging in Early Breast Cancer: SNB vs PET/MRI | completed | N/A | 246 | IRCCS San RaffaeleOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT04781959 | A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy | completed | Phase 4 | 233 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT04294225 | Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer | completed | Phase 2 | 161 | Mayo ClinicOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT00614172 | Proton Therapy for Early Stage Breast Cancer | completed | N/A | 50 | Loma Linda UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT04081389 | Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer | completed | Phase 1 | 9 | Roswell Park Cancer InstituteOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT06007118 | Adjuvant Partial-breast Irradiation Using Stereotactic Body Radiation Therapy | completed | N/A | 85 | Masaryk Memorial Cancer InstituteOTHER | 1 | Aug 23, 2023 | clinicaltrials |
| NCT00309478 | Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients | completed | Phase 3 | 1,099 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 0 | Jun 29, 2023 | clinicaltrials |
| NCT02335671 | Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy | completed | N/A | 40 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT04109391 | Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03 | completed | Phase 3 | 338 | Tanvex BioPharma USA, Inc.INDUSTRY | 10 | Oct 26, 2022 | clinicaltrials |
| NCT03948568 | Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)(REaCT-RETT) | completed | Phase 4 | 262 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT02698891 | Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer | completed | Phase 2 | 127 | Dana-Farber Cancer InstituteOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT03946683 | Cyberknife for Early Stage Breast Cancer | completed | N/A | 26 | NYU Langone HealthOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT03102307 | Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD) | completed | — | 548 | Kliniken Essen-MitteOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT03618017 | The ConnectedCancerCare Pilot Study (CCC)(CCC) | completed | N/A | 66 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT00309491 | Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients | completed | Phase 3 | 2,021 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 0 | Oct 19, 2020 | clinicaltrials |
| NCT00309569 | Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients | completed | Phase 3 | 429 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 0 | Oct 14, 2020 | clinicaltrials |
| NCT02485678 | A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer(AToM) | completed | N/A | 1,460 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Sep 3, 2020 | clinicaltrials |
| NCT03651921 | Testing of the Cancer Thriving and Surviving Breast Cancer Program(COSS) | completed | N/A | 39 | Manuela EicherOTHER | 1 | Aug 24, 2020 | clinicaltrials |
| NCT02159157 | A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast Cancer | completed | N/A | 28 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 21, 2020 | clinicaltrials |
| NCT01162200 | Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer | completed | Phase 1 | 75 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT02481128 | Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer | completed | N/A | 1,198 | Kliniken Essen-MitteOTHER | 2 | Jul 9, 2020 | clinicaltrials |
| NCT02441946 | A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer(neoMONARCH) | completed | Phase 2 | 224 | Eli Lilly and CompanyINDUSTRY | 10 | Jun 17, 2020 | clinicaltrials |
| NCT02816112 | Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia(REaCT-TC2) | completed | Phase 4 | 458 | Ottawa Hospital Research InstituteOTHER | 1 | May 27, 2020 | clinicaltrials |
| NCT03348696 | Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients(REaCT-TAPS) | completed | Phase 4 | 124 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 9, 2020 | clinicaltrials |
| NCT02816164 | A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia(REaCT-G2) | completed | Phase 4 | 324 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT02806817 | ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism | completed | Early Phase 1 | 40 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT03886389 | Breast Cancer Diet Intervention Study(BCDIS) | completed | N/A | 80 | Helse Stavanger HFOTHER_GOV | 0 | May 13, 2019 | clinicaltrials |
| NCT01871116 | POWER-remote Weight Loss Program in Early Stage Breast Cancer | completed | N/A | 96 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT03003611 | Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast Cancer | completed | — | 150 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01965522 | Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer(MELO-D) | completed | Phase 2 | 100 | Juravinski Cancer CenterOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT00165243 | Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer | completed | Phase 2 | 100 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT02310984 | PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional(PICTURE XS) | completed | — | 222 | University College, LondonOTHER | 3 | Mar 17, 2017 | clinicaltrials |
| NCT00665899 | A Couples Approach to Enhance Breast Cancer Survivorship(CanThrive) | completed | N/A | 163 | University of North Carolina, Chapel HillOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT00233077 | Patient Centered Randomized Controlled Trial | completed | N/A | 374 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Dec 3, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Jul 10, 2026source: clinicaltrials